AMINO ACIDS

Clinical safety rating: caution

Comprehensive clinical and safety monograph for AMINO ACIDS (AMINO ACIDS).

How it works

Amino acids are building blocks for protein synthesis and serve as precursors for neurotransmitters, hormones, and other nitrogenous compounds. They modulate nitrogen balance and support cellular repair and growth.

What the body does with it

Metabolism	Amino acids are metabolized primarily in the liver via transamination, deamination, and urea cycle. Specific pathways exist for each amino acid; excess nitrogen is converted to urea.
Excretion	Renal: >95% as amino acids and metabolites, primarily reabsorbed; <5% unchanged. Fecal/biliary: negligible (<1%).
Half-life	Variable; endogenous amino acids: 10–30 min for clearance from plasma; administered doses: distribution half-life ~5–10 min, terminal elimination half-life ~15–30 min, reflecting rapid metabolic utilization and renal reabsorption.
Protein binding	Minimal for most amino acids (<10%); albumin and globulins bind tryptophan and aromatic amino acids (~80–90% for tryptophan).
Volume of Distribution	0.4–0.6 L/kg (total body water); reflects equilibration with intracellular and extracellular fluid compartments.
Bioavailability	Oral: ~90–100% (active transport across intestinal mucosa); IV: 100%.
Onset of Action	IV: Immediate (within seconds to minutes); oral: 30–60 min (dependent on gastric emptying and absorption).
Duration of Action	IV: Metabolic effects persist 1–2 hours post-infusion; oral: 3–4 hours, influenced by protein synthesis rates and amino acid pool dynamics.

Classification & Brands

Dosing & administration

1-2 g/kg/day as continuous IV infusion or as a component of parenteral nutrition.

Dosage form	INJECTABLE
Renal impairment	For GFR <30 mL/min: reduce dose to 0.5-1 g/kg/day; monitor serum amino acids and nitrogen balance.
Liver impairment	Child-Pugh B or C: avoid standard formulations; use branched-chain amino acid (BCAA)-enriched solutions at 0.8-1.2 g/kg/day.
Pediatric use	0.5-2 g/kg/day IV; titrate based on age, growth, and metabolic needs.
Geriatric use	Initiate at 0.8 g/kg/day IV, adjust based on renal function and nitrogen balance; monitor for fluid overload.

Use during pregnancy

1st trimester	Consult provider
2nd trimester	Consult provider
3rd trimester	Consult provider

Clinical note

Comprehensive clinical and safety monograph for AMINO ACIDS (AMINO ACIDS).

Breastfeeding	Amino acids are normal constituents of breast milk; supplementation likely results in increased maternal levels but endogenous secretion maintains relatively constant milk levels. M/P ratio not established; generally considered compatible with breastfeeding at recommended doses.
Teratogenic Risk	Amino acids are essential nutrients; at physiologic doses, no teratogenic risk is established. At supraphysiologic doses, theoretical risk of metabolic imbalance exists. No trimester-specific human data; animal studies show no teratogenicity at standard doses.

Warnings & precautions

■ FDA Black Box Warning

Patients receiving amino acid infusions should be monitored for metabolic acidosis, hyperammonemia, and renal function impairment. Solutions with electrolytes should not be used in patients with severe electrolyte imbalances.

Side Effect Profile

Serious Effects

Absolute Contraindications

Hypersensitivity to any component, inborn errors of amino acid metabolism (e.g., phenylketonuria) without specific formula, severe hyperammonemia, anuria, or metabolic acidosis.

Clinical Precautions

Precautions	Use with caution in patients with renal impairment, hepatic failure, heart failure, or metabolic acidosis. Monitor serum electrolytes, blood urea nitrogen, and ammonia levels. Avoid rapid infusion to prevent hyperosmolarity and venous thrombosis.
Food/Dietary	No significant food interactions; however, enteral nutrition should be managed to avoid excessive protein intake. Patients with phenylketonuria must avoid phenylalanine-containing amino acid solutions.

Clinical Tips & Counseling

Drug interactions

Loading safety data…

AMINO ACIDS

Clinical safety rating: caution

Comprehensive clinical and safety monograph for AMINO ACIDS (AMINO ACIDS).

How it works

What the body does with it

Metabolism	Amino acids are metabolized primarily in the liver via transamination, deamination, and urea cycle. Specific pathways exist for each amino acid; excess nitrogen is converted to urea.
Excretion	Renal: >95% as amino acids and metabolites, primarily reabsorbed; <5% unchanged. Fecal/biliary: negligible (<1%).
Half-life	Variable; endogenous amino acids: 10–30 min for clearance from plasma; administered doses: distribution half-life ~5–10 min, terminal elimination half-life ~15–30 min, reflecting rapid metabolic utilization and renal reabsorption.
Protein binding	Minimal for most amino acids (<10%); albumin and globulins bind tryptophan and aromatic amino acids (~80–90% for tryptophan).
Volume of Distribution	0.4–0.6 L/kg (total body water); reflects equilibration with intracellular and extracellular fluid compartments.
Bioavailability	Oral: ~90–100% (active transport across intestinal mucosa); IV: 100%.
Onset of Action	IV: Immediate (within seconds to minutes); oral: 30–60 min (dependent on gastric emptying and absorption).
Duration of Action	IV: Metabolic effects persist 1–2 hours post-infusion; oral: 3–4 hours, influenced by protein synthesis rates and amino acid pool dynamics.

Classification & Brands

Dosing & administration

1-2 g/kg/day as continuous IV infusion or as a component of parenteral nutrition.

Dosage form	INJECTABLE
Renal impairment	For GFR <30 mL/min: reduce dose to 0.5-1 g/kg/day; monitor serum amino acids and nitrogen balance.
Liver impairment	Child-Pugh B or C: avoid standard formulations; use branched-chain amino acid (BCAA)-enriched solutions at 0.8-1.2 g/kg/day.
Pediatric use	0.5-2 g/kg/day IV; titrate based on age, growth, and metabolic needs.
Geriatric use	Initiate at 0.8 g/kg/day IV, adjust based on renal function and nitrogen balance; monitor for fluid overload.

Use during pregnancy

1st trimester	Consult provider
2nd trimester	Consult provider
3rd trimester	Consult provider

Clinical note

Comprehensive clinical and safety monograph for AMINO ACIDS (AMINO ACIDS).

Breastfeeding	Amino acids are normal constituents of breast milk; supplementation likely results in increased maternal levels but endogenous secretion maintains relatively constant milk levels. M/P ratio not established; generally considered compatible with breastfeeding at recommended doses.
Teratogenic Risk	Amino acids are essential nutrients; at physiologic doses, no teratogenic risk is established. At supraphysiologic doses, theoretical risk of metabolic imbalance exists. No trimester-specific human data; animal studies show no teratogenicity at standard doses.

Warnings & precautions

■ FDA Black Box Warning

Side Effect Profile

Serious Effects

Absolute Contraindications

Hypersensitivity to any component, inborn errors of amino acid metabolism (e.g., phenylketonuria) without specific formula, severe hyperammonemia, anuria, or metabolic acidosis.

Clinical Precautions

Precautions	Use with caution in patients with renal impairment, hepatic failure, heart failure, or metabolic acidosis. Monitor serum electrolytes, blood urea nitrogen, and ammonia levels. Avoid rapid infusion to prevent hyperosmolarity and venous thrombosis.
Food/Dietary	No significant food interactions; however, enteral nutrition should be managed to avoid excessive protein intake. Patients with phenylketonuria must avoid phenylalanine-containing amino acid solutions.

Clinical Tips & Counseling

Drug interactions

Loading safety data…

Clinical Pearls	Amino acid infusions should be administered via central line if osmolarity > 900 mOsm/L to prevent thrombophlebitis. Monitor serum ammonia and BUN in patients with hepatic or renal impairment. Use with caution in patients with inborn errors of amino acid metabolism.
Patient Advice	This medication provides essential building blocks for protein synthesis. · Report any signs of allergic reaction such as rash, itching, or difficulty breathing. · Inform your doctor if you have liver or kidney disease. · Do not take other protein supplements unless directed by your healthcare provider.